By Counterforce Health Team in Keppra (levetiracetam) —

How to Get Keppra (Levetiracetam) Covered by Blue Cross Blue Shield in Pennsylvania: PA Forms, Appeals, and Success Strategies

Answer Box: Getting Keppra Covered in Pennsylvania

To get Keppra (levetiracetam) covered by Blue Cross Blue Shield in Pennsylvania: First, check if prior authorization is required through your plan's member portal or formulary. Generic levetiracetam is typically preferred over brand Keppra and may be covered in Tier 1-2. If denied, you have strong appeal options—Pennsylvania's new external review program overturns about 50% of denials. Start today: Log into your Blue Cross portal to verify coverage requirements, or call the member services number on your insurance card.

Table of Contents

  1. Plan Types & Coverage Implications
  2. Formulary Status & Tier Placement
  3. Prior Authorization & Step Therapy Rules
  4. Submission Process & Required Forms
  5. Appeals Playbook for Pennsylvania
  6. Common Denial Reasons & Solutions
  7. Cost-Share Strategies & Savings Options
  8. When to Escalate to State Regulators

Plan Types & Coverage Implications

Pennsylvania has two major Blue Cross Blue Shield providers: Independence Blue Cross (IBX) serving southeastern Pennsylvania and Highmark Blue Shield covering western and northeastern regions. Your specific plan type affects how Keppra coverage works:

  • Commercial plans (purchased directly or through employers): Full Pennsylvania appeal rights apply
  • Medicare Advantage: Federal appeal timelines with Pennsylvania external review backup
  • Medicaid managed care: State-specific formulary with expedited appeal options
  • Self-funded employer plans: Use federal ERISA appeals process, not Pennsylvania's external review
Tip: Check your insurance card or call member services to confirm which Blue Cross plan you have and whether it's fully insured (eligible for Pennsylvania appeals) or self-funded.

Formulary Status & Tier Placement

Coverage at a Glance

Requirement Independence Blue Cross Highmark Blue Shield Where to Verify
Generic levetiracetam Tier 1-2 (preferred) Tier 1-2 (typical) IBX formulary
Brand Keppra Tier 3-4 (if covered) Tier 3-4 (if covered) Member portal or call
Prior authorization Plan-specific Plan-specific Online PA lookup tools
Step therapy Possible for brand Possible for brand Medical policy sections

Key insight: Generic levetiracetam is widely covered and cost-effective. Brand Keppra requests typically require "brand medically necessary" documentation showing generic failure or intolerance.

Prior Authorization & Step Therapy Rules

When PA is Required

Most Pennsylvania Blue Cross plans require prior authorization for:

  • Brand Keppra when generic levetiracetam is available
  • High-dose or extended-release formulations
  • Off-label uses beyond FDA-approved seizure indications

Step Therapy Protocol

Blue Cross step therapy for anti-seizure medications typically follows this sequence:

  1. First-line: Generic levetiracetam or other preferred anti-epileptic drugs
  2. Second-line: Non-preferred generics with documented trial/failure
  3. Third-line: Brand medications with medical necessity documentation

Medical necessity criteria for bypassing step therapy include:

  • Documented allergy or intolerance to generic formulations
  • Inadequate seizure control despite therapeutic levels
  • Specific formulation requirements (liquid, extended-release)
  • Drug interaction concerns with generic excipients

Submission Process & Required Forms

Step-by-Step: Fastest Path to Approval

  1. Verify requirements (Patient/Provider): Log into IBX member portal or Highmark provider portal to check current PA status
  2. Gather documentation (Provider): Collect seizure history, EEG results, medication trial logs, and current treatment plan
  3. Submit electronically (Provider): Use CoverMyMeds for Highmark or IBX's pharmacy portal for fastest processing
  4. Include medical justification (Provider): Document epilepsy diagnosis with ICD-10 codes, seizure frequency, and treatment goals
  5. Track status (Both): Monitor submission through provider portals; expect initial response in 72 hours to 2 business days
  6. Follow up if needed (Provider): Call IBX at 1-888-678-7012 or Highmark member services for status updates

Required Documentation

For all Keppra requests:

  • Patient demographics and insurance information
  • Prescriber details and DEA number
  • Epilepsy diagnosis with ICD-10 code (G40.x series)
  • Current seizure frequency and severity
  • Dosing rationale based on weight/age
  • Duration of treatment request

For brand Keppra specifically:

  • Documentation of generic levetiracetam trial with specific outcomes
  • Adverse reactions or intolerances to generic formulations
  • Clinical rationale for brand-specific requirements
  • Supporting literature if applicable
Clinician Corner: Strong medical necessity letters include specific seizure types (focal, generalized tonic-clonic, myoclonic), quantified seizure reduction goals, and references to FDA labeling for age-specific indications.

Appeals Playbook for Pennsylvania

Pennsylvania's appeals process gives you multiple chances to overturn denials, with a notably successful external review program.

Internal Appeals (Required First Step)

Timeline Action Required Contact Method
Within 60 days of denial Submit internal appeal with additional documentation Blue Cross member services or provider portal
15-30 days Receive Final Adverse Benefit Determination Written notice required by law

Pennsylvania External Review (After Internal Denial)

Pennsylvania's Independent External Review Program launched in 2024 with impressive results: approximately 50% of appeals are overturned, meaning the state forces insurers to cover treatments they initially denied.

Eligibility requirements:

  • Fully insured commercial plan (not self-funded)
  • Completed internal appeals process
  • Denial based on medical necessity, experimental treatment, or coverage determination
  • Submit within 4 months of final internal denial

Process timeline:

  • Standard review: 45 days from assignment to decision
  • Expedited review: 72 hours (for urgent health situations)
  • Additional evidence window: 15 days after reviewer assignment

How to file: Submit through Pennsylvania Insurance Department portal or mail/fax required forms.

Success tip: The external review program is free to patients (insurers pay the cost), and reviewers are independent physicians with no financial ties to insurance companies.

Common Denial Reasons & Solutions

Denial Reason Solution Strategy Required Documentation
"Generic available" Submit brand medical necessity form Documented generic trial/failure, specific adverse reactions
"Not medically necessary" Provide clinical evidence EEG results, seizure logs, treatment history, FDA labeling citations
"Quantity limit exceeded" Request quantity limit exception Weight-based dosing calculations, therapeutic drug monitoring levels
"Step therapy not completed" Document prior trials Pharmacy records, physician notes on previous anti-seizure medications
"Off-label use" Cite supporting literature Peer-reviewed studies, specialty guidelines, drug compendia references

Scripts for Common Situations

Patient calling Blue Cross member services: "I received a denial for my Keppra prescription. Can you tell me the specific reason and what documentation my doctor needs to provide for an appeal? I'd also like to know if there's a formulary exception process available."

Provider requesting peer-to-peer review: "I'm requesting a peer-to-peer review for a Keppra denial. My patient has documented seizure breakthrough on generic levetiracetam with specific adverse reactions. Can we schedule a clinical discussion with your medical director?"

Cost-Share Strategies & Savings Options

Even with coverage, Keppra costs can be significant. Here are verified savings strategies:

Manufacturer Support

  • UCB Patient Assistance Program: Income-based free medication for qualifying patients
  • Copay cards: Available for commercially insured patients (not Medicare/Medicaid)

Pennsylvania-Specific Resources

  • PACE/PACENET: Pennsylvania pharmaceutical assistance for seniors
  • Independence Blue Cross CivicaRx partnership: Generic medications at reduced costs (up to $45/month)
  • Highmark formulary alternatives: Check for preferred generic alternatives with lower copays

Alternative Coverage Strategies

If Keppra remains unaffordable:

  • Request therapeutic substitution to preferred formulary alternatives
  • Consider 90-day supplies for lower per-dose costs
  • Explore patient assistance foundations specific to epilepsy

When to Escalate to State Regulators

Contact the Pennsylvania Insurance Department if:

  • Blue Cross fails to respond within required timeframes
  • Internal appeal process seems unfair or incomplete
  • You suspect violations of Pennsylvania insurance law
  • External review decisions aren't being honored

Pennsylvania Insurance Department contacts:

  • Consumer Services: Available through pa.gov insurance section
  • External Review Program: Direct access through state portal
  • Complaint filing: Online forms available for coverage disputes

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed responses. The platform identifies specific denial reasons—whether prior authorization criteria, step therapy requirements, or medical necessity challenges—and drafts point-by-point rebuttals aligned with each plan's own rules, pulling the right medical evidence and citations to support coverage requests.

FAQ: Keppra Coverage in Pennsylvania

Q: How long does Blue Cross prior authorization take for Keppra? A: Electronic submissions typically receive initial responses within 72 hours to 2 business days. Paper submissions may take up to 14 days.

Q: What if Keppra isn't on my formulary at all? A: Request a formulary exception with medical necessity documentation. Pennsylvania law requires insurers to have an exception process for non-formulary medications.

Q: Can I get expedited approval for Keppra? A: Yes, if you can demonstrate urgent medical need (uncontrolled seizures, medication shortage). Both internal and external appeals offer expedited timelines.

Q: Does step therapy apply if I've been stable on Keppra from another state? A: Continuation of care provisions may apply. Document your treatment history and seizure control when submitting your PA request.

Q: What happens if I pay out-of-pocket during an appeal? A: Keep all receipts. If your appeal succeeds, Pennsylvania law requires insurers to reimburse out-of-pocket costs for covered services.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by specific plan and change frequently. Always verify current requirements with your insurance provider and consult your healthcare provider for medical decisions. For personalized assistance with complex appeals, consider working with Counterforce Health or other qualified patient advocacy services.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.